Formulation and storage of platelet-rich plasma homemade product

BioResearch Open Access

Volumn 1, Issue 3, 2012, Pages 115-123

  Bausset, Olivier ^a   Giraudo, Laurent ^a   Veran, Julie ^a   Magalon, Jeremy ^a   Coudreuse, Jean Marie ^b   Magalon, Guy ^a   Dubois, Christophe ^c   Serratrice, Nicolas ^a   Dignat George, Françoise ^a   Sabatier, Florence ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c University of the Mediterranean Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR AB; SOMATOMEDIN C; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD CLOT RETRACTION; BLOOD CLOTTING; BLOOD STORAGE; CELL ULTRASTRUCTURE; CENTRIFUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PURIFICATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE STRUCTURE; THROMBOELASTOGRAPHY;

EID: 84880839997     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0225     Document Type: Article

References (21)

1. Gosens T, Peerbooms JC, Van Laar W, et al. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39:1200-1208.
2. Peerbooms JC, Sluimer J, Bruijn DJ, et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year followup. Am J Sports Med. 2010;38:255-262.
3. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006; 34:1774-1778.
4. Anitua E, Sanchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42:162-170.
5. Pignatelli P, Pulcinelli FM, Ciatti F, et al. Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation. J Clin LabAnal. 1995;9:138-140.
6. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol. 1976;34:403-419.
7. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:81-90.
8. Tynngard N. Preparation, storage and quality control of platelet concentrates. Transfus Apher Sci. 2009;41:97-104.
9. Gutensohn K, Geidel K, Kroeger N, et al. Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses. Transfus Apher Sci. 2002;26:147-155.
10. Alonso-Escolano D, Strongin AY, Chung AW, et al. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol. 2004;141:241-252.
11. Radomski A, Jurasz P, Alonso-Escolano D, et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol. 2005;146:882-893.
12. Ehrenfest DM, Bielecki T, Del Corso M, et al. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A. 2010;95:1280-1282.
13. De Vos RJ, Weir A, Van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303:144-149.
14. Cho JM, Lee YH, Baek RM, et al. Effect of platelet-rich plasma on ultraviolet b-induced skin wrinkles in nude mice. J Plast Reconstr Aesthet Surg. 2010;641:e31-e39.
15. Jungbluth P, Wild M, Grassmann JP, et al. Platelet-rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini-pigs. J Orthop Res. 2010;28:1448-1455.
16. Cardigan R, Turner C, Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang. 2005;88:153-163.
17. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of plateletrich plasma gel preparation. J Oral Maxillofac Surg. 2000;58:297-300; discussion 301.
18. Weibrich G, Kleis WK, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003;14:357-362.
19. Weibrich G, KleisWK, Hafner G, et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002;30:97-102.
20. Apelseth TO, Bruserud O, Wentzel-Larsen T, et al. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion. 2007;47:653-665.
21. Moojen DJ, Everts PA, Schure RM, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26:404-410.